| Patient | Liliʻuokalani |
|---|---|
| Date of birth | 1838-09-02 |
| Identifiers | MRN HR-ET024-SYN-TD; SSN (made up) 000-24-3086 |
| Document date | 2026-11-01 |
| Author | Kealani Morrison-Takeda, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Urgent visit the morning after 20 minutes of right hand weakness and word-finding difficulty: examination, ABCD2 score, ECG and same-day emergency stroke evaluation with CT, CT angiography, swallow screen and antiplatelet loading, with culturally safe care and her ʻohana present at her choice. Concerns: She wants to keep playing and composing, and fears losing the use of her right hand or her words; She wants her ʻohana involved as she chooses, and her own Native Hawaiian ways of healing respected; She wants to be told plainly what is planned and to make her own decisions. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily for 21 days, after a 325 mg loading dose in the emergency department | One tablet daily for 21 days | Oral route | 1917-03-16 to 1917-04-06 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet daily, after a 300 mg loading dose in the emergency department | One tablet daily | Oral route | 1917-03-16 to 1917-04-20 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1917-03-16 | active | S |
| Losartan 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1917-03-23 | active | S |
| Apixaban 5 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 1917-04-20 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Twelve-lead electrocardiogram in the clinic: sinus rhythm at 72 per minute, normal intervals, no atrial fibrillation or acute changes | 1917-03-16 to 1917-03-16 | completed | S |
| Non-contrast CT of the head in the emergency department: no hemorrhage, no established infarct, mild age-related volume loss | 1917-03-16 to 1917-03-16 | completed | S |
| CT angiography of the head and neck: no large-vessel occlusion or intracranial stenosis; calcified plaque at the origin of the left internal carotid artery with less than 50% narrowing; right carotid and vertebral arteries normal | 1917-03-16 to 1917-03-16 | completed | S |
| MRI of the brain with diffusion-weighted imaging: an 8 mm acute infarct in the cortex of the left precentral gyrus; no hemorrhage; mild white matter changes of small-vessel disease | 1917-03-17 to 1917-03-17 | completed | S |
| Transthoracic echocardiography: ejection fraction 60%, mildly enlarged left atrium, no thrombus or valve vegetation, mild mitral annular calcification, no significant valve disease | 1917-03-17 to 1917-03-17 | completed | S |
| 30-day ambulatory electrocardiographic monitor (adhesive patch with an event recorder), applied at the stroke clinic | 1917-03-17 to 1917-03-17 | completed | S |
| Advance care planning conversation, about 25 minutes, with her consent and with the members of her ʻohana she invited | 1917-07-13 to 1917-07-13 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1917-07-13 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1917-07-13 | Respiratory syncytial virus vaccine, single dose | completed | S |
| 1917-08-24 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
| 1917-08-24 | Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| She wants to keep playing and composing, and fears losing the use of her right hand or her words | active | S |
| She wants her ʻohana involved as she chooses, and her own Native Hawaiian ways of healing respected | active | S |
| She wants to be told plainly what is planned and to make her own decisions | active | S |
Most recent measures: Total score [NIH Stroke Scale] 0 on 1917-03-17; Hemoglobin [Mass/volume] in Blood 12.7 on 1917-08-24; Platelets [#/volume] in Blood by Automated count 226 on 1917-08-24; Sodium [Moles/volume] in Serum or Plasma 139 on 1917-08-24; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1917-08-24; Creatinine [Mass/volume] in Serum or Plasma 0.88 on 1917-08-24; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M 67 on 1917-08-24; Glucose [Mass/volume] in Serum or Plasma 94 on 1917-08-24; INR in Platelet poor plasma by Coagulation assay 1 on 1917-03-16; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 1917-03-16; Cholesterol [Mass/volume] in Serum or Plasma 134 on 1917-08-24; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 on 1917-08-24; Cholesterol in HDL [Mass/volume] in Serum or Plasma 57 on 1917-08-24; Triglyceride [Mass/volume] in Serum or Plasma 90 on 1917-08-24; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 1917-04-20; Left ventricular Ejection fraction 60 on 1917-03-17; Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area 37 on 1917-03-17; Total score [MoCA] 27 on 1917-08-24; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1917-07-13; Modified rankin scale 1 on 1917-06-15; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1917-06-15; Total score [Mini-Cog] 5 on 1917-07-13; Total score [AUDIT-C] 1 on 1917-07-13 [S]
Strengths and supports: Strengths, supports and purpose: her music, her faith, her ʻohana, her work for the welfare of Hawaiian children, and a steadfast, composed manner [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Transient weakness and clumsiness of the right hand with word-finding difficulty, lasting about 20 minutes and fully resolved, the afternoon before the visit; suspected transient ischemic attack, ABCD2 score 5 (high risk); NIH Stroke Scale 0 | resolved | provisional | G45.9 | S — Synthetic presenting problem; resolved into the stroke diagnosis when diffusion MRI showed a small infarct at the stroke clinic the next day. Not a claim about her real symptoms. |
| Minor ischemic stroke: a small acute infarct in the cortex of the left precentral gyrus (left middle cerebral artery territory) on diffusion MRI, embolic in pattern, with full recovery (NIH Stroke Scale 0); source found to be paroxysmal atrial fibrillation; synthetic modern episode linked to her documented death from a stroke | active | confirmed | I63.412 | S — Synthetic modern diagnosis made at the stroke clinic the day after the visit; the 1917 cause of death remains D. |
| Hypertension: told of borderline readings in past years and not treated; 156/88 mmHg at intake | active | confirmed | I10 | S — Synthetic risk factor; no blood pressure from her lifetime is recorded in the cited sources. |
| Paroxysmal atrial fibrillation found on 30-day ambulatory monitoring after the stroke (six episodes, the longest 3 hours 10 minutes; burden about 3%); CHA2DS2-VASc 6, HAS-BLED 2 | active | confirmed | I48.0 | S — Synthetic finding on prolonged rhythm monitoring at five weeks. |
| Anterior nosebleed from the left side of the nasal septum four weeks after starting apixaban, stopped with pressure; hemoglobin unchanged; resolved | resolved | confirmed | R04.0 | S — Synthetic intercurrent problem at an unscheduled visit; a common minor bleed on an anticoagulant, not a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1917-03-16 | Total score [NIH Stroke Scale] | 0 | {score} | S | ||
| 1917-03-16 | Hemoglobin [Mass/volume] in Blood | 12.8 | g/dL | 11.6-15 g/dL | Normal | S |
| 1917-03-16 | Platelets [#/volume] in Blood by Automated count | 232 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1917-03-16 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1917-03-16 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1917-03-16 | Creatinine [Mass/volume] in Serum or Plasma | 0.82 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1917-03-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M | 73 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1917-03-16 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 1917-03-16 | INR in Platelet poor plasma by Coagulation assay | 1 | {INR} | 0.8-1.2 | Normal | S |
| 1917-03-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 1917-03-16 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 1917-03-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 132 | mg/dL | Goal below 70 mg/dL after ischemic stroke | High | S |
| 1917-03-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 | mg/dL | >=50 mg/dL | Normal | S |
| 1917-03-16 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 1917-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 16 | U/L | 7-35 U/L | Normal | S |
| 1917-03-17 | Total score [NIH Stroke Scale] | 0 | {score} | S | ||
| 1917-03-17 | Left ventricular Ejection fraction | 60 | % | 50-70% | Normal | S |
| 1917-03-17 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 37 | mL/m2 | <=34 mL/m² | High | S |
| 1917-03-17 | Total score [MoCA] | 26 | {score} | S | ||
| 1917-03-17 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1917-04-20 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1917-04-20 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1917-04-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.86 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1917-04-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M | 69 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1917-04-20 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 1917-04-20 | Hemoglobin [Mass/volume] in Blood | 12.7 | g/dL | 11.6-15 g/dL | Normal | S |
| 1917-04-20 | Platelets [#/volume] in Blood by Automated count | 228 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1917-04-20 | Cholesterol [Mass/volume] in Serum or Plasma | 138 | mg/dL | <=199 mg/dL | Normal | S |
| 1917-04-20 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 64 | mg/dL | Goal below 70 mg/dL after ischemic stroke | Normal | S |
| 1917-04-20 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 56 | mg/dL | >=50 mg/dL | Normal | S |
| 1917-04-20 | Triglyceride [Mass/volume] in Serum or Plasma | 92 | mg/dL | <=149 mg/dL | Normal | S |
| 1917-04-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-35 U/L | Normal | S |
| 1917-05-18 | Hemoglobin [Mass/volume] in Blood | 12.5 | g/dL | 11.6-15 g/dL | Normal | S |
| 1917-05-18 | Platelets [#/volume] in Blood by Automated count | 230 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1917-06-15 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1917-06-15 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1917-06-15 | Creatinine [Mass/volume] in Serum or Plasma | 0.84 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1917-06-15 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M | 71 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1917-06-15 | Glucose [Mass/volume] in Serum or Plasma | 95 | mg/dL | 70-99 mg/dL | Normal | S |
| 1917-06-15 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 11.6-15 g/dL | Normal | S |
| 1917-06-15 | Modified rankin scale | 1 | {score} | S | ||
| 1917-06-15 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1917-08-24 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1917-08-24 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1917-08-24 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1917-08-24 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M | 67 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1917-08-24 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1917-08-24 | Hemoglobin [Mass/volume] in Blood | 12.7 | g/dL | 11.6-15 g/dL | Normal | S |
| 1917-08-24 | Platelets [#/volume] in Blood by Automated count | 226 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1917-08-24 | Cholesterol [Mass/volume] in Serum or Plasma | 134 | mg/dL | <=199 mg/dL | Normal | S |
| 1917-08-24 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 62 | mg/dL | Goal below 70 mg/dL after ischemic stroke | Normal | S |
| 1917-08-24 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 57 | mg/dL | >=50 mg/dL | Normal | S |
| 1917-08-24 | Triglyceride [Mass/volume] in Serum or Plasma | 90 | mg/dL | <=149 mg/dL | Normal | S |
| 1917-08-24 | Total score [MoCA] | 27 | {score} | S | ||
| 1917-07-13 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1917-07-13 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 1917-07-13 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1917-03-16 | Body height | 160 | cm | S |
| 1917-03-16 | Body weight | 58 | kg | S |
| 1917-03-16 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 1917-03-16 | Systolic blood pressure | 156 | mm[Hg] | S |
| 1917-03-16 | Diastolic blood pressure | 88 | mm[Hg] | S |
| 1917-03-16 | Heart rate | 72 | /min | S |
| 1917-03-16 | Respiratory rate | 16 | /min | S |
| 1917-03-16 | Body temperature | 36.6 | Cel | S |
| 1917-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1917-03-17 | Body height | 160 | cm | S |
| 1917-03-17 | Body weight | 58 | kg | S |
| 1917-03-17 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 1917-03-17 | Systolic blood pressure | 148 | mm[Hg] | S |
| 1917-03-17 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 1917-03-17 | Heart rate | 70 | /min | S |
| 1917-03-17 | Respiratory rate | 16 | /min | S |
| 1917-03-17 | Body temperature | 36.7 | Cel | S |
| 1917-03-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1917-04-20 | Body height | 160 | cm | S |
| 1917-04-20 | Body weight | 57.8 | kg | S |
| 1917-04-20 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1917-04-20 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1917-04-20 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1917-04-20 | Heart rate | 74 | /min | S |
| 1917-04-20 | Respiratory rate | 16 | /min | S |
| 1917-04-20 | Body temperature | 36.6 | Cel | S |
| 1917-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1917-06-15 | Body height | 160 | cm | S |
| 1917-06-15 | Body weight | 57.6 | kg | S |
| 1917-06-15 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1917-06-15 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1917-06-15 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1917-06-15 | Heart rate | 70 | /min | S |
| 1917-06-15 | Respiratory rate | 16 | /min | S |
| 1917-06-15 | Body temperature | 36.6 | Cel | S |
| 1917-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1917-08-24 | Body height | 160 | cm | S |
| 1917-08-24 | Body weight | 57.8 | kg | S |
| 1917-08-24 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1917-08-24 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1917-08-24 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1917-08-24 | Heart rate | 70 | /min | S |
| 1917-08-24 | Respiratory rate | 16 | /min | S |
| 1917-08-24 | Body temperature | 36.5 | Cel | S |
| 1917-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1917-05-18 | Body height | 160 | cm | S |
| 1917-05-18 | Body weight | 57.8 | kg | S |
| 1917-05-18 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1917-05-18 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1917-05-18 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1917-05-18 | Heart rate | 78 | /min | S |
| 1917-05-18 | Respiratory rate | 16 | /min | S |
| 1917-05-18 | Body temperature | 36.6 | Cel | S |
| 1917-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1917-07-13 | Body height | 160 | cm | S |
| 1917-07-13 | Body weight | 57.6 | kg | S |
| 1917-07-13 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1917-07-13 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1917-07-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1917-07-13 | Heart rate | 68 | /min | S |
| 1917-07-13 | Respiratory rate | 16 | /min | S |
| 1917-07-13 | Body temperature | 36.6 | Cel | S |
| 1917-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1917-03-16 | Urgent visit the morning after 20 minutes of right hand weakness and word-finding difficulty: examination, ABCD2 score, ECG and same-day emergency stroke evaluation with CT, CT angiography, swallow screen and antiplatelet loading, with culturally safe care and her ʻohana present at her choice | finished | S |
| 1917-03-17 | Stroke clinic the next morning: diffusion MRI, echocardiogram, 30-day rhythm monitor, cognition screen and vascular neurology consultation | finished | S |
| 1917-04-20 | Five-week review: rhythm monitor result, anticoagulation decision, lipids, kidney function and blood pressure | finished | S |
| 1917-06-15 | Three-month review after the stroke: function, mood, blood pressure, apixaban safety and falls | finished | S |
| 1917-08-24 | Five-month review: blood pressure, lipids, apixaban safety, cognition and plans for the months ahead | finished | S |
| 1917-05-18 | Same-day sick visit for a nosebleed on apixaban | finished | S |
| 1917-07-13 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Culturally safe, trauma-informed care: address her as Liliʻuokalani, as she asked; take time; explain each test and treatment plainly before it is done; involve her ʻohana as she chooses while she makes the decisions; acknowledge the history of the overthrow when she raises it, without probing | completed | GL-AHA-PCAS-2021, GL-KEOLAMAMO, GL-PL103-150 | S |
| Same-day emergency stroke evaluation today (CT, CT angiography of the head and neck, swallow screen and laboratory tests), then vascular neurology consultation at the rapid-access stroke clinic tomorrow morning, with diffusion MRI and an echocardiogram | completed | GL-AHA-STROKE-2021, GL-ABCD2-2007, GL-CMID-2026 | S |
| Dual antiplatelet therapy started within 24 hours of onset once CT excluded bleeding: aspirin 325 mg and clopidogrel 300 mg loading doses, then aspirin 81 mg and clopidogrel 75 mg daily for 21 days, then a single antiplatelet; stop antiplatelets if anticoagulation is started | completed | GL-AHA-STROKE-2021, GL-POINT-2018, GL-CHANCE-2013 | S |
| Atorvastatin 40 mg daily, a high-intensity statin, with a lipid panel at four to twelve weeks; LDL goal below 70 mg/dL | completed | GL-AHA-STROKE-2021, GL-CMID-2026 | S |
| Bedside swallow screen before any food or drink, a cognition screen (MoCA) at the stroke clinic, a depression screen, and a falls assessment | completed | GL-AHA-STROKE-2021, GL-AHA-PCAS-2021, GL-CMID-2026 | S |
| BE FAST: balance, eyes, face, arm, speech, time to call 911; call 911 at once for any new symptom, even if it passes, and do not drive herself | completed | GL-CDC-BEFAST, GL-AHA-STROKE-2021 | S |
| Native Hawaiian healing alongside clinic care, if she wishes: lomilomi through Ke Ola Mamo, a Native Hawaiian Health Care System, with the practitioner told that she takes blood thinners, and hoʻoponopono with her ʻohana as they choose; the clinic asks nothing further about her practices | completed | GL-KEOLAMAMO | S |
| Blood pressure: home readings twice daily for a week; if the average is 130/80 mmHg or higher after the first week, start losartan 25 mg daily, with potassium and creatinine two weeks later; target below 130/80 mmHg | completed | GL-AHA-STROKE-2021, GL-AHA-HTN-2025, GL-CMID-2026 | S |
| Rhythm monitoring for atrial fibrillation for 30 days with an ambulatory patch, because the stroke is embolic in pattern; if atrial fibrillation is found, stop antiplatelets and start a direct oral anticoagulant | completed | GL-AHA-STROKE-2021, GL-ACC-ARRH-2024, GL-AF-2023 | S |
| Apixaban 5 mg twice daily for paroxysmal atrial fibrillation (CHA2DS2-VASc 6, HAS-BLED 2), with clopidogrel stopped; blood count and kidney function before starting and about every five to six months at her age and kidney function; bleeding precautions, no anti-inflammatory pain medicines, and a falls plan | completed | GL-AF-2023, GL-AHA-STROKE-2021, GL-CMID-2026 | S |
| Laboratory tests drawn at clinic visits, or at home by the clinic's nurse, instead of separate trips to the laboratory | completed | GL-CMID-2026 | S |
| Daily walking, the foods she already eats with less salted and preserved food, alcohol kept to rare occasions, and no smoking | completed | GL-AHA-STROKE-2021, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| No recurrent stroke or transient ischemic attack | 1917-08-24 | active | None in five months on dual antiplatelets, then apixaban | S |
| LDL cholesterol below 70 mg/dL | 1917-04-20 | completed | 132 to 64 mg/dL on atorvastatin 40 mg | S |
| Blood pressure below 130/80 mmHg at home and in the clinic | 1917-06-15 | completed | 126/74 in the clinic; home average 124/72 | S |
| Anticoagulation that is safe and taken as prescribed, without major bleeding | 1917-08-24 | active | Apixaban 5 mg twice daily from five weeks; one minor nosebleed, controlled at home and in the clinic; no missed doses | S |
| Keep playing the piano and composing | 1917-06-15 | completed | Playing daily; modified Rankin Scale 1 at three months | S |